HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pablo Caviedes Selected Research

Calcium

1/2018RCAN1 Knockdown Reverts Defects in the Number of Calcium-Induced Exocytotic Events in a Cellular Model of Down Syndrome.
7/2012Altered voltage dependent calcium currents in a neuronal cell line derived from the cerebral cortex of a trisomy 16 fetal mouse, an animal model of Down syndrome.
1/2006Altered calcium currents in cultured sensory neurons of normal and trisomy 16 mouse fetuses, an animal model for human trisomy 21 (Down syndrome).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pablo Caviedes Research Topics

Disease

13Down Syndrome (Down's Syndrome)
03/2020 - 09/2002
5Dysferlinopathy
06/2020 - 01/2016
5Parkinson Disease (Parkinson's Disease)
08/2012 - 11/2002
3Muscular Dystrophies (Muscular Dystrophy)
06/2020 - 01/2016
3Alzheimer Disease (Alzheimer's Disease)
01/2014 - 02/2010
2Atrophy
01/2020 - 01/2017
2Congenital Structural Myopathies (Centronuclear Myopathy)
01/2017 - 09/2013
1Fatigue
06/2020
1Hypoparathyroidism
01/2017
1Muscular Diseases (Myopathy)
01/2017
1Nervous System Diseases (Neurological Disorders)
01/2014
1Mitochondrial Diseases (Mitochondrial Disease)
11/2012
1Neurodegenerative Diseases (Neurodegenerative Disease)
08/2012
1Neuromuscular Diseases (Neuromuscular Disease)
01/2012
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2012
1Hepatolenticular Degeneration (Wilson's Disease)
05/2009
1Parkinsonian Disorders (Parkinsonism)
05/2009
1Edema (Dropsy)
07/2004
1Necrosis
07/2004

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
01/2020 - 11/2006
5DysferlinIBA
06/2020 - 01/2016
5aminochrome 1 (aminochrome)IBA
08/2012 - 11/2002
4Amyloid (Amyloid Fibrils)IBA
02/2010 - 11/2006
3CalciumIBA
01/2018 - 01/2006
3Cholinergic Agents (Cholinergics)IBA
11/2017 - 09/2002
3Dynamin IIIBA
01/2017 - 09/2013
2neuromelaninIBA
08/2012 - 06/2011
2Dopamine (Intropin)FDA LinkGeneric
07/2004 - 11/2002
1AntioxidantsIBA
06/2020
1Mitogen-Activated Protein KinasesIBA
03/2020
1Glycogen Synthase KinasesIBA
03/2020
1Creatine Kinase (Creatine Phosphokinase)IBA
01/2020
1Actins (F Actin)IBA
12/2019
1Inositol (Myoinositol)IBA
11/2017
1p21-Activated KinasesIBA
01/2016
1Cell Adhesion MoleculesIBA
01/2016
1ConnexinsIBA
01/2016
1Connexin 43 (Connexin43)IBA
01/2016
1tau Proteins (tau Protein)IBA
11/2012
1NicotineFDA Link
08/2012
1Therapeutic UsesIBA
08/2012
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
08/2012
1Nicotinic AgonistsIBA
08/2012
1DystrophinIBA
01/2012
1Peptides (Polypeptides)IBA
02/2010
1Amyloid beta-PeptidesIBA
02/2010
1CopperIBA
05/2009
1Levodopa (L Dopa)FDA LinkGeneric
09/2007
1CholesterolIBA
08/2007
1NeurotoxinsIBA
07/2004
1Fluorescent Dyes (Fluorescent Probes)IBA
07/2004
1Dicumarol (Dicoumarol)FDA Link
07/2004
1NAD(P)H Dehydrogenase (Quinone) (Quinone Reductase)IBA
07/2004
1Hydroxyl RadicalIBA
07/2004
1EnzymesIBA
07/2004
1Free RadicalsIBA
11/2002
1Neurotransmitter Receptors (Neurotransmitter Receptor)IBA
09/2002

Therapy/Procedure

3Therapeutics
01/2019 - 09/2007